NADH Measured by Laser Fluorimetry in Skeletal Muscle in McArdle's Disease
- 25 June 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (26) , 1664-1665
- https://doi.org/10.1056/nejm198706253162614
Abstract
To the Editor: It has recently been reported that monitoring of NADH fluorescence can be used for the detection of abnormalities in oxidative metabolism in the human myocardium.1 NAD is reduced to NADH during the oxidative catabolism of various substrates consumed by muscles. NADH oxidation regenerates NAD and produces ATP mainly in the mitochondria. In patients with McArdle's disease (muscular phosphorylase deficiency), muscle glycogen cannot be broken down, and it has been suggested that one of the most important consequences is a deficiency in oxidative substrates, resulting in a limited production of NADH.2 We used a laser fluorimeter3 to perform . . .Keywords
This publication has 5 references indexed in Scilit:
- Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysisNeurology, 1987
- DETECTION OF REGIONAL MYOCARDIAL ISCHAEMIA BY NADH LASER FLUORIMETRY DURING HUMAN LEFT HEART CATHETERISATIONThe Lancet, 1986
- The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigueJournal of Applied Physiology, 1986
- NADH and NADPH in human skeletal muscle at rest and during ischaemiaClinical Physiology and Functional Imaging, 1983
- A laser fluorimeter for direct cardiac metabolism investigationOptics & Laser Technology, 1982